Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO)

CUSIP: 984015602

Q4 2024 13F Holders as of 31 Dec 2024

Type / Class
Equity / Common Stock, $0.001 par value per share
Shares outstanding
2,291,515
Total 13F shares
89,449
Share change
+40,685
Total reported value
$356,056
Price per share
$4.00
Number of holders
13
Value change
+$160,445
Number of buys
5
Number of sells
4

Quarterly Holders Quick Answers

What is CUSIP 984015602?
CUSIP 984015602 identifies XBIO - Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) as of Q4 2024

As of 31 Dec 2024, Xenetic Biosciences, Inc. - Common Stock, $0.001 par value per share (XBIO) was held by 13 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 89,449 shares. The largest 10 holders included RENAISSANCE TECHNOLOGIES LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC, GEODE CAPITAL MANAGEMENT, LLC, LGT Group Foundation, Sachetta, LLC, JTC Employer Solutions Trustee Ltd, UBS Group AG, Alexis Investment Partners, LLC, and BANK OF AMERICA CORP /DE/. This page lists 13 institutional shareholders reporting positions in this security for the Q4 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.